Fluorine in PDB 7mng: Crystal Structure of Sars-Cov-2 Main Protease (3CLPRO/Mpro) in Complex with Covalent Inhibitor Vby-825 (Partial Occupancy)
Enzymatic activity of Crystal Structure of Sars-Cov-2 Main Protease (3CLPRO/Mpro) in Complex with Covalent Inhibitor Vby-825 (Partial Occupancy)
All present enzymatic activity of Crystal Structure of Sars-Cov-2 Main Protease (3CLPRO/Mpro) in Complex with Covalent Inhibitor Vby-825 (Partial Occupancy):
3.4.22.69;
Protein crystallography data
The structure of Crystal Structure of Sars-Cov-2 Main Protease (3CLPRO/Mpro) in Complex with Covalent Inhibitor Vby-825 (Partial Occupancy), PDB code: 7mng
was solved by
B.Andi,
D.Kumaran,
A.S.Soares,
D.F.Kreitler,
W.Shi,
J.Jakoncic,
M.R.Fuchs,
J.Keereetaweep,
J.Shanklin,
S.Mcsweeney,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
28.16 /
1.70
|
Space group
|
C 1 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
114.706,
53.896,
44.75,
90,
101.1,
90
|
R / Rfree (%)
|
18 /
21.8
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Crystal Structure of Sars-Cov-2 Main Protease (3CLPRO/Mpro) in Complex with Covalent Inhibitor Vby-825 (Partial Occupancy)
(pdb code 7mng). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 8 binding sites of Fluorine where determined in the
Crystal Structure of Sars-Cov-2 Main Protease (3CLPRO/Mpro) in Complex with Covalent Inhibitor Vby-825 (Partial Occupancy), PDB code: 7mng:
Jump to Fluorine binding site number:
1;
2;
3;
4;
5;
6;
7;
8;
Fluorine binding site 1 out
of 8 in 7mng
Go back to
Fluorine Binding Sites List in 7mng
Fluorine binding site 1 out
of 8 in the Crystal Structure of Sars-Cov-2 Main Protease (3CLPRO/Mpro) in Complex with Covalent Inhibitor Vby-825 (Partial Occupancy)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Crystal Structure of Sars-Cov-2 Main Protease (3CLPRO/Mpro) in Complex with Covalent Inhibitor Vby-825 (Partial Occupancy) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F401
b:38.2
occ:0.35
|
F1
|
A:ZL7401
|
0.0
|
38.2
|
0.3
|
C15
|
A:ZL7401
|
1.4
|
37.9
|
0.3
|
C14
|
A:ZL7401
|
2.3
|
38.2
|
0.3
|
C16
|
A:ZL7401
|
2.4
|
40.4
|
0.3
|
O
|
A:HIS41
|
2.6
|
23.4
|
1.0
|
O
|
A:CYS44
|
3.0
|
33.5
|
1.0
|
CB
|
A:CYS44
|
3.4
|
26.3
|
1.0
|
C13
|
A:ZL7401
|
3.6
|
40.0
|
0.3
|
C
|
A:CYS44
|
3.6
|
31.5
|
1.0
|
C17
|
A:ZL7401
|
3.6
|
43.4
|
0.3
|
CG2
|
A:THR25
|
3.7
|
32.4
|
1.0
|
C
|
A:HIS41
|
3.8
|
21.0
|
1.0
|
CD2
|
A:HIS41
|
3.9
|
23.6
|
1.0
|
CA
|
A:CYS44
|
3.9
|
27.1
|
1.0
|
SD
|
A:MET49
|
3.9
|
42.7
|
1.0
|
N
|
A:CYS44
|
4.1
|
26.7
|
1.0
|
C12
|
A:ZL7401
|
4.1
|
45.2
|
0.5
|
CG
|
A:MET49
|
4.2
|
43.3
|
1.0
|
OG1
|
A:THR25
|
4.2
|
30.5
|
1.0
|
CB
|
A:HIS41
|
4.3
|
20.6
|
1.0
|
CG
|
A:HIS41
|
4.5
|
21.3
|
1.0
|
N
|
A:THR45
|
4.5
|
33.5
|
1.0
|
CB
|
A:THR25
|
4.5
|
30.6
|
1.0
|
CA
|
A:HIS41
|
4.6
|
20.5
|
1.0
|
SG
|
A:CYS44
|
4.7
|
30.3
|
1.0
|
C17
|
A:ZL7401
|
4.7
|
76.2
|
0.7
|
N
|
A:VAL42
|
4.7
|
19.4
|
1.0
|
C22
|
A:ZL7401
|
4.8
|
60.4
|
0.5
|
C
|
A:THR45
|
4.9
|
42.3
|
1.0
|
CA
|
A:THR45
|
4.9
|
41.0
|
1.0
|
CA
|
A:VAL42
|
4.9
|
19.8
|
1.0
|
C
|
A:VAL42
|
4.9
|
22.4
|
1.0
|
C22
|
A:ZL7401
|
4.9
|
61.0
|
0.5
|
NE2
|
A:HIS41
|
5.0
|
23.7
|
1.0
|
|
Fluorine binding site 2 out
of 8 in 7mng
Go back to
Fluorine Binding Sites List in 7mng
Fluorine binding site 2 out
of 8 in the Crystal Structure of Sars-Cov-2 Main Protease (3CLPRO/Mpro) in Complex with Covalent Inhibitor Vby-825 (Partial Occupancy)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Crystal Structure of Sars-Cov-2 Main Protease (3CLPRO/Mpro) in Complex with Covalent Inhibitor Vby-825 (Partial Occupancy) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F401
b:56.0
occ:0.65
|
F1
|
A:ZL7401
|
0.0
|
56.0
|
0.7
|
C15
|
A:ZL7401
|
1.4
|
70.0
|
0.7
|
O
|
A:HOH759
|
1.9
|
30.0
|
0.5
|
C16
|
A:ZL7401
|
2.3
|
74.7
|
0.7
|
C14
|
A:ZL7401
|
2.3
|
63.9
|
0.7
|
O
|
A:HOH501
|
2.5
|
30.0
|
0.5
|
CG
|
A:MET165
|
3.3
|
29.0
|
0.5
|
O
|
A:HIS164
|
3.6
|
20.2
|
1.0
|
C17
|
A:ZL7401
|
3.6
|
76.2
|
0.7
|
C13
|
A:ZL7401
|
3.6
|
75.3
|
0.7
|
O
|
A:HOH672
|
3.6
|
49.0
|
1.0
|
CE
|
A:MET49
|
3.6
|
40.8
|
1.0
|
C12
|
A:ZL7401
|
4.1
|
80.9
|
0.5
|
CG
|
A:MET165
|
4.1
|
29.0
|
0.5
|
CB
|
A:MET165
|
4.2
|
26.8
|
0.5
|
CB
|
A:MET165
|
4.2
|
26.8
|
0.5
|
C1
|
A:ZL7401
|
4.2
|
50.3
|
0.5
|
CE1
|
A:HIS41
|
4.3
|
25.8
|
1.0
|
ND1
|
A:HIS41
|
4.3
|
26.1
|
1.0
|
CA
|
A:MET165
|
4.3
|
23.0
|
0.5
|
O4
|
A:ZL7401
|
4.4
|
65.2
|
0.5
|
CA
|
A:MET165
|
4.4
|
23.0
|
0.5
|
O4
|
A:ZL7401
|
4.4
|
58.1
|
0.5
|
C1
|
A:ZL7401
|
4.4
|
57.8
|
0.5
|
SD
|
A:MET165
|
4.4
|
38.8
|
0.5
|
SD
|
A:MET165
|
4.4
|
38.8
|
0.5
|
CE
|
A:MET165
|
4.4
|
37.2
|
0.5
|
C
|
A:HIS164
|
4.5
|
18.8
|
1.0
|
O
|
A:HOH702
|
4.7
|
54.9
|
1.0
|
CA
|
A:ASP187
|
4.7
|
20.0
|
1.0
|
N
|
A:ARG188
|
4.7
|
23.0
|
1.0
|
C
|
A:ASP187
|
4.7
|
22.1
|
1.0
|
NE2
|
A:HIS41
|
4.8
|
23.7
|
1.0
|
CG
|
A:HIS41
|
4.8
|
21.3
|
1.0
|
F2
|
A:ZL7401
|
4.8
|
54.9
|
0.5
|
CB
|
A:ASP187
|
4.9
|
19.0
|
1.0
|
C13
|
A:ZL7401
|
4.9
|
40.0
|
0.3
|
N
|
A:MET165
|
4.9
|
18.3
|
1.0
|
|
Fluorine binding site 3 out
of 8 in 7mng
Go back to
Fluorine Binding Sites List in 7mng
Fluorine binding site 3 out
of 8 in the Crystal Structure of Sars-Cov-2 Main Protease (3CLPRO/Mpro) in Complex with Covalent Inhibitor Vby-825 (Partial Occupancy)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Crystal Structure of Sars-Cov-2 Main Protease (3CLPRO/Mpro) in Complex with Covalent Inhibitor Vby-825 (Partial Occupancy) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F401
b:54.9
occ:0.50
|
F2
|
A:ZL7401
|
0.0
|
54.9
|
0.5
|
F2
|
A:ZL7401
|
1.2
|
85.7
|
0.5
|
C18
|
A:ZL7401
|
1.3
|
57.2
|
0.3
|
C12
|
A:ZL7401
|
1.6
|
80.9
|
0.5
|
C13
|
A:ZL7401
|
1.6
|
75.3
|
0.7
|
C18
|
A:ZL7401
|
1.7
|
86.3
|
0.7
|
C11
|
A:ZL7401
|
1.9
|
81.2
|
0.5
|
F3
|
A:ZL7401
|
2.1
|
76.7
|
0.5
|
F4
|
A:ZL7401
|
2.1
|
54.7
|
0.5
|
C11
|
A:ZL7401
|
2.4
|
48.8
|
0.5
|
F3
|
A:ZL7401
|
2.5
|
85.9
|
0.5
|
C17
|
A:ZL7401
|
2.8
|
76.2
|
0.7
|
C14
|
A:ZL7401
|
2.8
|
63.9
|
0.7
|
C12
|
A:ZL7401
|
2.8
|
45.2
|
0.5
|
O
|
A:HOH745
|
2.8
|
30.0
|
0.8
|
F4
|
A:ZL7401
|
2.9
|
85.3
|
0.5
|
C13
|
A:ZL7401
|
3.0
|
40.0
|
0.3
|
N2
|
A:ZL7401
|
3.1
|
78.6
|
0.5
|
N2
|
A:ZL7401
|
3.2
|
52.7
|
0.5
|
CG
|
A:MET49
|
3.5
|
43.3
|
1.0
|
C15
|
A:ZL7401
|
3.5
|
70.0
|
0.7
|
C16
|
A:ZL7401
|
3.6
|
74.7
|
0.7
|
NE2
|
A:GLN189
|
3.6
|
44.5
|
0.8
|
CB
|
A:MET49
|
3.7
|
41.4
|
1.0
|
C17
|
A:ZL7401
|
3.9
|
43.4
|
0.3
|
C14
|
A:ZL7401
|
4.2
|
38.2
|
0.3
|
C5
|
A:ZL7401
|
4.4
|
76.3
|
0.5
|
CB
|
A:GLN189
|
4.4
|
32.8
|
1.0
|
CD
|
A:GLN189
|
4.4
|
41.5
|
0.8
|
C5
|
A:ZL7401
|
4.5
|
53.0
|
0.5
|
CE
|
A:MET49
|
4.5
|
40.8
|
1.0
|
F1
|
A:ZL7401
|
4.8
|
56.0
|
0.7
|
CG
|
A:GLN189
|
4.8
|
38.0
|
1.0
|
SD
|
A:MET49
|
4.8
|
42.7
|
1.0
|
C16
|
A:ZL7401
|
4.8
|
40.4
|
0.3
|
C15
|
A:ZL7401
|
4.9
|
37.9
|
0.3
|
O
|
A:HOH662
|
4.9
|
52.4
|
1.0
|
O
|
A:HOH757
|
4.9
|
49.2
|
1.0
|
O
|
A:HOH501
|
4.9
|
30.0
|
0.5
|
N1
|
A:ZL7401
|
5.0
|
62.0
|
0.5
|
|
Fluorine binding site 4 out
of 8 in 7mng
Go back to
Fluorine Binding Sites List in 7mng
Fluorine binding site 4 out
of 8 in the Crystal Structure of Sars-Cov-2 Main Protease (3CLPRO/Mpro) in Complex with Covalent Inhibitor Vby-825 (Partial Occupancy)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Crystal Structure of Sars-Cov-2 Main Protease (3CLPRO/Mpro) in Complex with Covalent Inhibitor Vby-825 (Partial Occupancy) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F401
b:85.7
occ:0.50
|
F2
|
A:ZL7401
|
0.0
|
85.7
|
0.5
|
C18
|
A:ZL7401
|
1.2
|
57.2
|
0.3
|
F2
|
A:ZL7401
|
1.2
|
54.9
|
0.5
|
F3
|
A:ZL7401
|
1.3
|
76.7
|
0.5
|
C18
|
A:ZL7401
|
1.3
|
86.3
|
0.7
|
F4
|
A:ZL7401
|
1.6
|
54.7
|
0.5
|
F4
|
A:ZL7401
|
2.2
|
85.3
|
0.5
|
F3
|
A:ZL7401
|
2.2
|
85.9
|
0.5
|
C11
|
A:ZL7401
|
2.4
|
81.2
|
0.5
|
O
|
A:HOH745
|
2.4
|
30.0
|
0.8
|
C13
|
A:ZL7401
|
2.4
|
75.3
|
0.7
|
C12
|
A:ZL7401
|
2.6
|
80.9
|
0.5
|
C11
|
A:ZL7401
|
2.7
|
48.8
|
0.5
|
NE2
|
A:GLN189
|
2.7
|
44.5
|
0.8
|
N2
|
A:ZL7401
|
3.4
|
78.6
|
0.5
|
CD
|
A:GLN189
|
3.5
|
41.5
|
0.8
|
C12
|
A:ZL7401
|
3.5
|
45.2
|
0.5
|
N2
|
A:ZL7401
|
3.5
|
52.7
|
0.5
|
C14
|
A:ZL7401
|
3.6
|
63.9
|
0.7
|
C17
|
A:ZL7401
|
3.9
|
76.2
|
0.7
|
CB
|
A:MET49
|
4.0
|
41.4
|
1.0
|
C13
|
A:ZL7401
|
4.0
|
40.0
|
0.3
|
CB
|
A:GLN189
|
4.1
|
32.8
|
1.0
|
CG
|
A:GLN189
|
4.1
|
38.0
|
1.0
|
OE1
|
A:GLN189
|
4.1
|
44.8
|
0.8
|
CG
|
A:MET49
|
4.2
|
43.3
|
1.0
|
C17
|
A:ZL7401
|
4.4
|
43.4
|
0.3
|
C15
|
A:ZL7401
|
4.6
|
70.0
|
0.7
|
O
|
A:HOH756
|
4.7
|
36.3
|
1.0
|
O
|
A:HOH662
|
4.7
|
52.4
|
1.0
|
C5
|
A:ZL7401
|
4.8
|
76.3
|
0.5
|
C16
|
A:ZL7401
|
4.8
|
74.7
|
0.7
|
O
|
A:HOH757
|
4.9
|
49.2
|
1.0
|
C5
|
A:ZL7401
|
5.0
|
53.0
|
0.5
|
|
Fluorine binding site 5 out
of 8 in 7mng
Go back to
Fluorine Binding Sites List in 7mng
Fluorine binding site 5 out
of 8 in the Crystal Structure of Sars-Cov-2 Main Protease (3CLPRO/Mpro) in Complex with Covalent Inhibitor Vby-825 (Partial Occupancy)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 5 of Crystal Structure of Sars-Cov-2 Main Protease (3CLPRO/Mpro) in Complex with Covalent Inhibitor Vby-825 (Partial Occupancy) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F401
b:76.7
occ:0.50
|
F3
|
A:ZL7401
|
0.0
|
76.7
|
0.5
|
F3
|
A:ZL7401
|
1.0
|
85.9
|
0.5
|
C18
|
A:ZL7401
|
1.0
|
86.3
|
0.7
|
C18
|
A:ZL7401
|
1.3
|
57.2
|
0.3
|
F2
|
A:ZL7401
|
1.3
|
85.7
|
0.5
|
F4
|
A:ZL7401
|
1.7
|
85.3
|
0.5
|
F2
|
A:ZL7401
|
2.1
|
54.9
|
0.5
|
F4
|
A:ZL7401
|
2.2
|
54.7
|
0.5
|
C11
|
A:ZL7401
|
2.4
|
48.8
|
0.5
|
C11
|
A:ZL7401
|
2.5
|
81.2
|
0.5
|
NE2
|
A:GLN189
|
2.9
|
44.5
|
0.8
|
C12
|
A:ZL7401
|
3.2
|
45.2
|
0.5
|
C12
|
A:ZL7401
|
3.3
|
80.9
|
0.5
|
N2
|
A:ZL7401
|
3.4
|
78.6
|
0.5
|
N2
|
A:ZL7401
|
3.6
|
52.7
|
0.5
|
C13
|
A:ZL7401
|
3.6
|
75.3
|
0.7
|
O
|
A:HOH745
|
3.6
|
30.0
|
0.8
|
C17
|
A:ZL7401
|
3.7
|
43.4
|
0.3
|
CD
|
A:GLN189
|
3.9
|
41.5
|
0.8
|
C13
|
A:ZL7401
|
4.1
|
40.0
|
0.3
|
CB
|
A:MET49
|
4.1
|
41.4
|
1.0
|
CG
|
A:MET49
|
4.3
|
43.3
|
1.0
|
OE1
|
A:GLN189
|
4.3
|
44.8
|
0.8
|
O
|
A:HOH756
|
4.4
|
36.3
|
1.0
|
OG
|
A:SER46
|
4.4
|
51.8
|
1.0
|
CA
|
A:SER46
|
4.5
|
52.3
|
1.0
|
C17
|
A:ZL7401
|
4.5
|
76.2
|
0.7
|
CB
|
A:SER46
|
4.5
|
51.5
|
1.0
|
O
|
A:SER46
|
4.6
|
50.3
|
1.0
|
C5
|
A:ZL7401
|
4.6
|
76.3
|
0.5
|
C5
|
A:ZL7401
|
4.8
|
53.0
|
0.5
|
C14
|
A:ZL7401
|
4.8
|
63.9
|
0.7
|
CG
|
A:GLN189
|
4.9
|
38.0
|
1.0
|
CB
|
A:GLN189
|
4.9
|
32.8
|
1.0
|
C16
|
A:ZL7401
|
4.9
|
40.4
|
0.3
|
|
Fluorine binding site 6 out
of 8 in 7mng
Go back to
Fluorine Binding Sites List in 7mng
Fluorine binding site 6 out
of 8 in the Crystal Structure of Sars-Cov-2 Main Protease (3CLPRO/Mpro) in Complex with Covalent Inhibitor Vby-825 (Partial Occupancy)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 6 of Crystal Structure of Sars-Cov-2 Main Protease (3CLPRO/Mpro) in Complex with Covalent Inhibitor Vby-825 (Partial Occupancy) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F401
b:85.9
occ:0.50
|
F3
|
A:ZL7401
|
0.0
|
85.9
|
0.5
|
F3
|
A:ZL7401
|
1.0
|
76.7
|
0.5
|
C18
|
A:ZL7401
|
1.3
|
86.3
|
0.7
|
C18
|
A:ZL7401
|
1.7
|
57.2
|
0.3
|
C11
|
A:ZL7401
|
2.0
|
48.8
|
0.5
|
F2
|
A:ZL7401
|
2.2
|
85.7
|
0.5
|
F4
|
A:ZL7401
|
2.2
|
85.3
|
0.5
|
C11
|
A:ZL7401
|
2.4
|
81.2
|
0.5
|
F2
|
A:ZL7401
|
2.5
|
54.9
|
0.5
|
C12
|
A:ZL7401
|
2.6
|
45.2
|
0.5
|
F4
|
A:ZL7401
|
2.8
|
54.7
|
0.5
|
C17
|
A:ZL7401
|
2.9
|
43.4
|
0.3
|
N2
|
A:ZL7401
|
3.4
|
78.6
|
0.5
|
N2
|
A:ZL7401
|
3.4
|
52.7
|
0.5
|
C12
|
A:ZL7401
|
3.4
|
80.9
|
0.5
|
OG
|
A:SER46
|
3.6
|
51.8
|
1.0
|
NE2
|
A:GLN189
|
3.7
|
44.5
|
0.8
|
C13
|
A:ZL7401
|
3.7
|
40.0
|
0.3
|
CA
|
A:SER46
|
3.7
|
52.3
|
1.0
|
CB
|
A:SER46
|
3.8
|
51.5
|
1.0
|
CG
|
A:MET49
|
4.0
|
43.3
|
1.0
|
C13
|
A:ZL7401
|
4.0
|
75.3
|
0.7
|
C16
|
A:ZL7401
|
4.1
|
40.4
|
0.3
|
CB
|
A:MET49
|
4.1
|
41.4
|
1.0
|
O
|
A:SER46
|
4.3
|
50.3
|
1.0
|
C5
|
A:ZL7401
|
4.4
|
76.3
|
0.5
|
C17
|
A:ZL7401
|
4.4
|
76.2
|
0.7
|
C5
|
A:ZL7401
|
4.5
|
53.0
|
0.5
|
O
|
A:HOH745
|
4.5
|
30.0
|
0.8
|
C
|
A:SER46
|
4.5
|
54.2
|
1.0
|
O
|
A:HOH756
|
4.6
|
36.3
|
1.0
|
C14
|
A:ZL7401
|
4.7
|
38.2
|
0.3
|
N
|
A:SER46
|
4.7
|
50.9
|
1.0
|
CD
|
A:GLN189
|
4.7
|
41.5
|
0.8
|
C15
|
A:ZL7401
|
4.8
|
37.9
|
0.3
|
C6
|
A:ZL7401
|
4.8
|
103.2
|
0.5
|
O3
|
A:ZL7401
|
4.9
|
127.3
|
0.5
|
C6
|
A:ZL7401
|
4.9
|
102.8
|
0.5
|
|
Fluorine binding site 7 out
of 8 in 7mng
Go back to
Fluorine Binding Sites List in 7mng
Fluorine binding site 7 out
of 8 in the Crystal Structure of Sars-Cov-2 Main Protease (3CLPRO/Mpro) in Complex with Covalent Inhibitor Vby-825 (Partial Occupancy)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 7 of Crystal Structure of Sars-Cov-2 Main Protease (3CLPRO/Mpro) in Complex with Covalent Inhibitor Vby-825 (Partial Occupancy) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F401
b:54.7
occ:0.50
|
F4
|
A:ZL7401
|
0.0
|
54.7
|
0.5
|
C18
|
A:ZL7401
|
1.3
|
57.2
|
0.3
|
F4
|
A:ZL7401
|
1.4
|
85.3
|
0.5
|
C18
|
A:ZL7401
|
1.5
|
86.3
|
0.7
|
F2
|
A:ZL7401
|
1.6
|
85.7
|
0.5
|
C11
|
A:ZL7401
|
2.1
|
81.2
|
0.5
|
F2
|
A:ZL7401
|
2.1
|
54.9
|
0.5
|
F3
|
A:ZL7401
|
2.2
|
76.7
|
0.5
|
N2
|
A:ZL7401
|
2.3
|
78.6
|
0.5
|
C11
|
A:ZL7401
|
2.4
|
48.8
|
0.5
|
O
|
A:HOH745
|
2.6
|
30.0
|
0.8
|
N2
|
A:ZL7401
|
2.6
|
52.7
|
0.5
|
C13
|
A:ZL7401
|
2.6
|
75.3
|
0.7
|
C12
|
A:ZL7401
|
2.7
|
80.9
|
0.5
|
F3
|
A:ZL7401
|
2.8
|
85.9
|
0.5
|
O
|
A:HOH662
|
3.1
|
52.4
|
1.0
|
O
|
A:HOH756
|
3.3
|
36.3
|
1.0
|
C12
|
A:ZL7401
|
3.7
|
45.2
|
0.5
|
C5
|
A:ZL7401
|
3.8
|
76.3
|
0.5
|
O
|
A:HOH757
|
3.8
|
49.2
|
1.0
|
C14
|
A:ZL7401
|
3.9
|
63.9
|
0.7
|
NE2
|
A:GLN189
|
4.0
|
44.5
|
0.8
|
C5
|
A:ZL7401
|
4.0
|
53.0
|
0.5
|
C17
|
A:ZL7401
|
4.0
|
76.2
|
0.7
|
C13
|
A:ZL7401
|
4.2
|
40.0
|
0.3
|
C6
|
A:ZL7401
|
4.4
|
103.2
|
0.5
|
CD
|
A:GLN189
|
4.4
|
41.5
|
0.8
|
C6
|
A:ZL7401
|
4.5
|
102.8
|
0.5
|
C4
|
A:ZL7401
|
4.6
|
70.1
|
0.5
|
C17
|
A:ZL7401
|
4.7
|
43.4
|
0.3
|
OE1
|
A:GLN189
|
4.8
|
44.8
|
0.8
|
N1
|
A:ZL7401
|
4.8
|
62.0
|
0.5
|
N1
|
A:ZL7401
|
4.8
|
52.1
|
0.5
|
C1
|
A:ZL7401
|
4.9
|
57.8
|
0.5
|
C15
|
A:ZL7401
|
4.9
|
70.0
|
0.7
|
C4
|
A:ZL7401
|
4.9
|
54.4
|
0.5
|
C16
|
A:ZL7401
|
5.0
|
74.7
|
0.7
|
|
Fluorine binding site 8 out
of 8 in 7mng
Go back to
Fluorine Binding Sites List in 7mng
Fluorine binding site 8 out
of 8 in the Crystal Structure of Sars-Cov-2 Main Protease (3CLPRO/Mpro) in Complex with Covalent Inhibitor Vby-825 (Partial Occupancy)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 8 of Crystal Structure of Sars-Cov-2 Main Protease (3CLPRO/Mpro) in Complex with Covalent Inhibitor Vby-825 (Partial Occupancy) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F401
b:85.3
occ:0.50
|
F4
|
A:ZL7401
|
0.0
|
85.3
|
0.5
|
C18
|
A:ZL7401
|
1.3
|
86.3
|
0.7
|
F4
|
A:ZL7401
|
1.4
|
54.7
|
0.5
|
C18
|
A:ZL7401
|
1.6
|
57.2
|
0.3
|
F3
|
A:ZL7401
|
1.7
|
76.7
|
0.5
|
F2
|
A:ZL7401
|
2.2
|
85.7
|
0.5
|
C11
|
A:ZL7401
|
2.2
|
48.8
|
0.5
|
F3
|
A:ZL7401
|
2.2
|
85.9
|
0.5
|
C11
|
A:ZL7401
|
2.3
|
81.2
|
0.5
|
N2
|
A:ZL7401
|
2.5
|
78.6
|
0.5
|
O
|
A:HOH756
|
2.7
|
36.3
|
1.0
|
N2
|
A:ZL7401
|
2.7
|
52.7
|
0.5
|
F2
|
A:ZL7401
|
2.9
|
54.9
|
0.5
|
C12
|
A:ZL7401
|
3.5
|
80.9
|
0.5
|
O
|
A:HOH662
|
3.5
|
52.4
|
1.0
|
C12
|
A:ZL7401
|
3.6
|
45.2
|
0.5
|
O
|
A:HOH745
|
3.7
|
30.0
|
0.8
|
C5
|
A:ZL7401
|
3.7
|
76.3
|
0.5
|
C13
|
A:ZL7401
|
3.8
|
75.3
|
0.7
|
C5
|
A:ZL7401
|
4.0
|
53.0
|
0.5
|
C6
|
A:ZL7401
|
4.0
|
103.2
|
0.5
|
C6
|
A:ZL7401
|
4.1
|
102.8
|
0.5
|
NE2
|
A:GLN189
|
4.1
|
44.5
|
0.8
|
C17
|
A:ZL7401
|
4.3
|
43.4
|
0.3
|
C13
|
A:ZL7401
|
4.6
|
40.0
|
0.3
|
CD
|
A:GLN189
|
4.7
|
41.5
|
0.8
|
C17
|
A:ZL7401
|
4.8
|
76.2
|
0.7
|
OE1
|
A:GLN189
|
4.8
|
44.8
|
0.8
|
C4
|
A:ZL7401
|
4.9
|
70.1
|
0.5
|
O
|
A:HOH714
|
5.0
|
47.1
|
1.0
|
O
|
A:HOH757
|
5.0
|
49.2
|
1.0
|
OG
|
A:SER46
|
5.0
|
51.8
|
1.0
|
|
Reference:
B.Andi,
D.Kumaran,
D.F.Kreitler,
A.S.Soares,
W.Shi,
J.Jakoncic,
M.R.Fuchs,
J.Keereetaweep,
J.Shanklin,
S.Mcsweeney.
Hepatitis C Virus NS3/4A Inhibitors and Other Drug-Like Compounds As Efficient Covalent Binders of Sars-Cov-2 3CL Main Protease To Be Published.
Page generated: Fri Aug 2 09:40:51 2024
|